We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Point of Care

Image: An early sepsis recognition platform could be more rapid, affordable and accessible (Photo courtesy of Pexels)

Early Sepsis Recognition Platform Could Identify Pre-Symptomatic Patients at POC Using Culture-Free Diagnostic Test

A new diagnostic system for early-stage sepsis condition could allow doctors to predict the future appearance and evolution of sepsis within a short period of time and thus, provide a suitable clinical response even before the symptoms arise. More...
14 Nov 2022
Image: A breakthrough technology intends to reshape the future of diagnostic testing (Photo courtesy of IdentifySensors)

New Digital Platform Technology Aims to Disrupt 50-Year-Old PCR Testing for Similar-Symptom Pathogens

A disruptive new diagnostic testing platform that uses electronic nanosensors to detect the genetic material of numerous pathogens could reshape the future of diagnostic testing. More...
14 Nov 2022
Image: Photo of the group’s circuit board for the biosensor (Photo courtesy of University of Florida)

Hand-Held POC Biosensor Quickly and Accurately Detects Oral Cancer

Researchers have developed a breakthrough hand-held biosensor that enables quick and accurate detection of oral cancer. The team is now looking forward to demonstrating their integrated solution for cancer and other disease detection via a hand-held point-of-care device with a short detection time and low detection limit. More...
14 Nov 2022
Image: Nanōmix eLab is a mobile, hand-held immunoassay and chemistry diagnostic system (Photo courtesy of Nanomix)

Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System

Mast Group Limited (Liverpool, UK) and Nanomix (Emeryville, CA, USA) have entered into a multi-region distribution agreement wherein Mast will market and distribute the Nanōmix eLab system in the UK, Germany, France, Ireland and South Africa. More...
14 Nov 2022
Image: USENSe is designed for POC detection of uropathogens causing UTI in 15 minutes (Photo courtesy of Module Innovations)

Rapid Credit Card-Sized UTI Diagnostic Test Detects Four Major Uropathogens from Urine Drop

Urinary Tract Infections (UTIs) are also the second-highest infections in the human body and account for significant GP visits and economic burden on our healthcare system. The empirical prescription of antibiotics is eventually adding up to the larger problem of Anti Microbial Resistance (AMR). Now, a point-of-care solution leverages the power of nanotechnology and biotechnology for ultra rapid diagnosis of UTI. More...
13 Nov 2022
Image: Helge is a patented CE-marked concept for point of care hemolysis detection (Photo courtesy of Hemcheck Sweden)

Novel POC Hemolysis System Improves Patient Care, Reduces Workload for Emergency Departments and ICUs

An innovative product concept enables the detection of hemolysed blood samples in direct connection with blood sampling near the patient, contributing to increased patient safety, more efficient processes and lower costs. More...
13 Nov 2022
Image: Pixl Real-time PCR Platform (Photo courtesy of BioGX)

Portable qPCR Platform Enables Faster, Better, Low-Cost Near-Patient Molecular Diagnosis

The point-of-care molecular diagnostics space seems to have gotten more crowded during COVID. Now, a portable molecular diagnostics platform with 16-well capabilities differentiates itself from most competitors who use single cartridge or single test formats. More...
12 Nov 2022
Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
ow Frequency Pulse Massager
ET10 L


The HospiMedica Point-of-Care Testing channel provides reporting on clinical/medical testing that is performed at the patient's side, near the patient and outside of the clinical laboratory. This would include testing provided by healthcare professionals and remote/field personnel and does not require processing by a central laboratory.